anticogulant role in covid

1. Depates in
anticoagulant role for
COVID
DR TAREK HAMDY
LECTURER OF CHEST DISEASES

2. ARE WE OVER USING ANTICOAGULANT IN
COVID PATIENTS ?

3. MANY QUISTIONTS ?
• WHEN TO USE?
• WHAT TO USE?
• HOW LONG WILL WE USE ?
• IS IT IMPORTATNT TO USE?
• IS THERE GUIDELINES IN USE ?
• IS THERE CONTEROVERSES IN USE ?

34. Prophylaxis and treatment of venous thromboembolism in cirrhosis Patients with cirrhosis are at
increased risk for venous thromboembolism, specifically portal vein thrombosis.
• The non-portal venous system thromboembolism incidence is anywhere from 0.5–8.1% in patients with cirrhosis, with
increasing risk as Childs-Pugh score worsens .
• Despite their high risk of thrombosis, there is no consensus on prophylactic or therapeutic treatment with anticoagulation
in patients with cirrhosis. Most people are treated if they have the diagnosis of an acute symptomatic PVT, the presence of
another type of DVT, risk factors for thrombosis, or if they are pre-liver transplant patients .